RxDoctor Payments Data

Aaron Young, DO

Critical Care Medicine · Ashland, OHNPI 1740574219

Payments from drug & device makers

$594in general payments, 2019–2025

Across 30 payments — averaging $19.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Otsuka America Pharmaceutical, Inc.$214
  • Bayer$98
  • AstraZeneca$50
  • Amgen$36
  • Mallinckrodt Hospital Products Inc.$29
  • Akebia Therapeutics Inc$29
  • plus $138 from 8 others

What the payments were for

  • Food & beverage$41770%
  • Education$17730%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
22
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$594 in reported general payments places this provider in the 65th percentile of 285 critical care medicine providers in Ohio.

See all critical care medicine providers in Ohio

Medicare billing

Part B allowed, 2024
$142,041
Medicare patients
348
Services billed
980

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin118$91,944
FarxigaDapagliflozin Propanediol37$45,057
JanuviaSitagliptin Phosphate16$15,143
EliquisApixaban21$11,696
CorlanorIvabradine Hcl12$3,578
Nifedipine ErNifedipine114$3,366
Potassium Chloride58$2,783
Atorvastatin Calcium140$2,267
Lantus SolostarInsulin Glargine,hum.Rec.Anlog13$2,154
Budesonide14$2,024
Potassium Citrate ErPotassium Citrate16$1,965
Fluticasone-SalmeterolFluticasone Propion/Salmeterol11$1,772
Bumetanide53$1,619
Sevelamer Carbonate18$1,247
Spironolactone67$1,228

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AstraZenecaFarxiga$50$45,05737 claims
MerckJanuvia$12$15,14316 claims
AmgenCorlanor$36$3,57812 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 285 critical care medicine providers in Ohio.

Other critical care medicine in Ashland

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →